Source: Annual Congress 2011 - Allergen immunotherapy and anti-immunoglobulin E
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Stanziola, E. Carpentieri, C. Vitale, M. Pitassi, N. Sorrentino, M. Sofia (Naples, Italy). Omalizumab and voriconazole in allergic broncopulmonary aspergillosis (A case series). Eur Respir J 2011; 38: Suppl. 55, 276

Member's Comments

No comment yet.

Related content which might interest you: Retrospective study on the combined use of voriconazole and prednisolone in the treatment of acute allergic bronchopulmonary aspergillosis (ABPA). Source: International Congress 2019 – Understanding, monitoring and targeting severe asthma Year: 2019 Omalizumab in patients with allergic bronchopulmonary aspergillosis (ABPA): a multicenter case series study in Spain Source: Annual Congress 2009 - Persistent asthma: still an uncontrolled disease requiring new treatments strategies in 2009 Year: 2009 Complex treatment of allergic bronchopulmonary aspergillosis (ABPA) in asthmatic patient including anti-IgE therapy – A case report Source: Annual Congress 2012 - Phenotypes and mechanisms of treatment of asthma Year: 2012 A randomised trial of voriconazole and prednisolone monotherapy in acute-stage allergic bronchopulmonary aspergillosis complicating asthma Source: Eur Respir J, 52 (3) 1801159; 10.1183/13993003.01159-2018 Year: 2018 Itraconazole and allergic bronchopulmonary aspergillosis: long-term follow-up Source: Eur Respir J 2001; 18: Suppl. 33, 432s Year: 2001 Effect of itraconazole therapy on disease course in 3 cases of allergic bronchopulmonary mycosis presented as refractory asthma Source: Annual Congress 2008 - Allergy and immunology of asthma and beyond Year: 2008 Follow-up of patients with allergic bronchopulmonary aspergillosis (ABPA) - side effects of long-term therapy Source: Eur Respir J 2003; 22: Suppl. 45, 237s Year: 2003 Improvement in asthma severity and control by voriconazole and posaconazole in severe asthma with fungal sensitization (SAFS) and ABPA Source: Annual Congress 2012 - Exacerbations of asthma and COPD: assessment, impact and novel treatments Year: 2012 Treatment of chronic necrotizing pulmonary aspergillosis (CNPA) with micafungin (MCFG) Source: Eur Respir J 2005; 26: Suppl. 49, 410s Year: 2005 Concurrent allergic bronchopulmonary aspergillosis and aspergilloma: is it a more severe form of the disease? Source: Eur Respir Rev 2010 19: 261-263 Year: 2010 Super-response to dupilumab therapy in a patient with severe asthma and ABPA – a case report Source: Virtual Congress 2020 – Monoclonal antibodies in asthma Year: 2020 Pulse methylprednisolone in allergic bronchopulmonary aspergillosis exacerbations Source: Eur Respir Rev 2014; 23: 149-152 Year: 2014 Treatment options in severe fungal asthma and allergic bronchopulmonary aspergillosis Source: Eur Respir J 2014; 43: 1487-1500 Year: 2014 Place of azoles in the treatment of allergic bronchopulmonary candidiasis Source: Eur Respir J 2006; 28: Suppl. 50, 52s Year: 2006 Voriconazole treatment in CF patients with ABPA and/or invasive aspergillosis Source: Annual Congress 2010 - New aspects of cystic fibrosis Year: 2010 Bronchopulmonary aspergillosis Source: Respipedia Article Year: 2017 Caspofungin pulses for CPA (chronic pulmonary aspergillosis): A retrospective study Source: International Congress 2016 – Severe respiratory infections in the intensive care unit and pleural and fungal infections Year: 2016 Serum level directed itraconazole therapy in allergic bronchopulmonary aspergillosis Source: International Congress 2016 – Molecular immunology of the lung Year: 2016 Allergic bronchopulmonary aspergillosis and other fungal diseases Source: Eur Respir Mon 2011; 52: 97-114 Year: 2011 A randomised trial of glucocorticoids in acute-stage allergic bronchopulmonary aspergillosis complicating asthma Source: Eur Respir J 2016; 47: 490-498 Year: 2016